Skip to content
Search AI Powered

Latest Stories

Margin delivery rate increases from October

The Pharmaceutical Services Negotiating Committee (PSNC) has announced that the margin delivery rates will increase from October as the agreed £100m write-off is implemented.

“The baseline margin allowance will remain £800m per year in 2022/23 and 2023/24,” said the PSNC.


“Margin levels in the last two full years (2020/21 and 2021/22), as measured by the Margin Survey of independent pharmacies, were in excess of the baseline allowance, meaning that an excess was accrued.”

It also added: “In October 2022 there will be a modest uplift to Drug Tariff prices, and further uplifts will also be enacted in subsequent Drug Tariffs in 2022/23 and 2023/24 (subject to forecasts of pharmacy contractor margin retention levels being accurate).”

The Single Activity Fee (SAF) will stay set at £1.27 as enter the second half of 2022/23. However, the SAF may be subject to change later in 2022/23 or in 2023/24, depending on prescription volume expectations and overall fee delivery rates.

Transitional Payments were originally scheduled to end in March 2021 but PSNC has successfully negotiated for their extension in subsequent years.

As new services have been introduced and take up of these has accelerated, the amount of unallocated funding left in the CPCF is now less than it previously was. As such, the value of the Transitional Payments will decrease from its current level. Some of the unallocated funding remaining in 2023/24 will be repurposed into a Flat Payment for all contractors (see details below).

Over the course of the second half of 2022/23, the value of the Transitional Payments will be phased down. This will start in October 2022 with a reduction in payment levels to approximately 85% of the current level, as shown in the following table:

Number of items per month from 1 October 2022Monthly Dispensing Payment of the Transitional Payment from 1 October 2022Monthly Service Payment of the Transitional Payment from October 2022
0 – 100£0£0
101 – 2,500£51.55£51.55
2,501 – 5,000£600.60£600.60
5,001 – 12,500£757.84£757.84
12,501 – 19,167£821.42£821.42
19,168+£853.22£853.22

Further significant reductions will also be needed before March 2023. Funding delivery levels will be monitored on a month-by-month basis by PSNC and DHSC, in order to determine the appropriate level for the Transitional Payments as we approach March 2023.

In addition to the reduction in the value of the Transitional Payments, there will also be an increase in the proportion of these payments linked to service delivery. From November 2022, the ‘service element’ of the Transitional Payment will make up 75% of the value of the Transitional Payment.

From April 2023, a new flat payment will be made to all contractors dispensing at least 101 items per month. The total funding allocation for the flat payment will be £70m annually.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less